Impact of Early PCSK9 Inhibitor on Heart After Acute Myocardium Infarction

NCT04731155 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Early PCSK9 Inhibitor on Ventricular Remodling

Interventions

DRUG: PCSK9 inhibitor （Alirocumab）plus standard medications
DRUG: standard medications

Sponsor

Shanghai Tong Ren Hospital